KIMBERLY PHILLIPS: Open Payments
NPI 1316387764 · LAWRENCEBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 95 payments from 23 companies in 2025. Trend: 2023 $1,785 · 2024 $1,919 · 2025 $1,847
Food & beverage: $1,847
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $334 |
| AstraZeneca Pharmaceuticals LP | 15 | $266 |
| Novo Nordisk Inc | 9 | $214 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Amgen Inc. | 9 | $147 |
| GlaxoSmithKline, LLC. | 6 | $125 |
| Verona Pharma, Inc. | 5 | $110 |
| Almatica Pharma LLC | 3 | $88 |
| Insulet Corporation | 3 | $53 |
| Alkermes, Inc. | 2 | $49 |
Products named: AIRSUPRA, FANAPT, Ozempic, VRAYLAR, TRELEGY ELLIPTA, OTEZLA, Ohtuvayre, QULIPTA.
Industry payments across KY — which companies pay providers there.
